Viralytics (ASX:VLA) will be granted a European patent covering a wider group of oncolytic viruses that bind to ICAM-1, target of the company’s Cavatak candidate. [ + ]

Compumedics (ASX:CMP) expects to report a loss for FY13, but is projecting a return to profitability in 1H14 as it resolves its order-backlog issues. [ + ]

Legendary media editor, businesswoman and 2013 Australian of the Year Ita Buttrose will be the guest dinner speaker at next week’s Research Australia 2013 Philanthropy for Health and Medical Research conference. [ + ]

The University of New South Wales responds to claims that the research into the antiskin cancer drug, DZ13, was flawed. Clinical trials have been suspended as a third round of investigations continue. [ + ]

ComBio 2013 will be held from 29 September to 3 October 2013 at the Perth Convention Centre. The program will feature 17 plenary presentations from highly regarded international scientists, plus six society speciality lectures. [ + ]

Scientists, engineers, researchers and teachers are now encouraged to submit nominations for the NSW Science and Engineering Awards. [ + ]

The 2014 winner of what is widely regarded as the Nobel prize for soil science, the Dokuchaev award, is an Australian researcher. [ + ]

Cochlear Limited (ASX:COH) reported a net profit for FY13 of $132.6m - up 133% year on year, but down 16% when excluding the costs of a product recall in FY12. [ + ]

IP law expert Geraldine Farrell will join Melbourne-based Nexvet as the company’s VP of operations and general counsel. [ + ]

Viralytics (ASX:VLA) ADRs are now being traded on the US-based OTCQX International marketplace. [ + ]

When a plastic bag floats in the ocean it looks like a jellyfish, especially to a hungry turtle swimming by. [ + ]

From 9.00 am to 8.00 pm on 28 and 29 September, sightseers will have the chance to explore the laboratories, technical halls, experiments and accelerators at the biggest particle physics centre in the world - CERN. [ + ]

The board of Standards Australia has announced the appointment of Dr Bronwyn Evans as chief executive officer. Dr Evans will replace incumbent CEO Colin Blair following his retirement and is due to commence on 28 October 2013. [ + ]

Research from the University of Western Australia (UWA) could have a significant impact on the treatment of ear infections, reducing the need for antibiotics and surgery and tackling hearing loss in Indigenous communities. [ + ]

Researchers at Technische Universität München (TUM) have decoded the proteome of 59 tumour cell lines from the US National Cancer Institute, known as the ‘NCI-60’ cell lines, which represent the most common tumour diseases in nine tissues (eg, brain, breast, bowels, skin, blood). [ + ]